Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Therapeutic effects and mechanisms of isoxanthohumol on DSS-induced colitis: regulating T cell development, restoring gut microbiota, and improving metabolic disorders
Publication Year: 2024 Source: Inflammopharmacology PMID: 38642223
No Abstract
TOpCLASS Expert Consensus Classification of Perianal Fistulising Crohn's Disease: A Real-world Application in a Serial Fistula MRI Cohort
Publication Year: 2024 Source: J Crohns Colitis PMID: 38642332
No Abstract
Surgical management of complicated Crohn's disease
Publication Year: 2024 Source: Semin Pediatr Surg PMID: 38642531
No Abstract
Microbial metabolite deoxycholic acid-mediated ferroptosis exacerbates high-fat diet-induced colonic inflammation
Publication Year: 2024 Source: Mol Metab PMID: 38642891
No Abstract
Navigating Postoperative Management in Crohn's Disease: Insights from the PORCSE Study
Publication Year: 2024 Source: J Crohns Colitis PMID: 38642911
No Abstract
Artificial intelligence-assisted colonoscopy to identify histologic remission and predict the outcomes of patients with ulcerative colitis: A systematic review
Publication Year: 2024 Source: Dig Liver Dis PMID: 38643020
No Abstract
Comment on "Echopattern parameter as an aid to profile Crohn's disease patients"
Publication Year: 2024 Source: Dig Liver Dis PMID: 38643021
No Abstract
Editorial: Exploring the influence of diet on later-onset ulcerative colitis-Are eggs and spicy foods the key factors in Asia?
Publication Year: 2024 Source: Aliment Pharmacol Ther PMID: 38643502 DOI: 10.1111/apt.17983
No Abstract
Editorial: Foretelling the future-Emerging role of magnetic resonance enterography as a prognostic tool in Crohn's disease
Publication Year: 2024 Source: Aliment Pharmacol Ther PMID: 38643503
No Abstract
Label-free cell phenotypic profiling of histamine H4R receptor and discovery of non-competitive H4R antagonist from natural products
Publication Year: 2024 Source: Bioorg Chem PMID: 38643561 DOI: 10.1016/j.bioorg.2024.107387
Histamine 4 receptor (H4R), the most recently identified subtype of histamine receptor, primarily induces inflammatory reactions upon activation. Several H4R antagonists have been developed for the treatment of inflammatory bowel disease (IBD) and atopic dermatitis (AD), but their use has been limited by adverse side effects, such as a short …
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide